Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Nijmeh

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Cell Biochemistry and Biophysics|June 27, 2021
Lipid-Derived Mediators are Pivotal to Leukocyte and Lung Cell Responses in Sepsis and ARDSJulie Nijmeh, Bruce D Levy
American Journal of Physiology. Lung Cellular and Molecular Physiology|August 10, 2010
Role of ROS in ischemia-induced lung angiogenesisJulie Nijmeh, Aigul Moldobaeva, Elizabeth M Wagner
Expert Review of Respiratory Medicine|November 25, 2017
Emerging biomarkers of lymphangioleiomyomatosisJulie Nijmeh, Souheil El-Chemaly, Elizabeth P Henske
Experimental Biology and Medicine (Maywood, N.J.)|October 14, 2023
Respiratory viral infection and resolution of inflammation: Roles for specialized pro-resolving mediatorsLuciana P Tavares, Julie Nijmeh, Bruce D Levy
The Journal of Pathology|October 19, 2016
New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complexHilaire C Lam, Julie Nijmeh, Elizabeth P Henske
Current Opinion in Clinical Nutrition and Metabolic Care|December 26, 2021
Specialized pro-resolving mediators in respiratory diseasesR Elaine Cagnina, Melody G Duvall, Julie Nijmeh, et al.
Human Molecular Genetics|July 5, 2019
Loss of FLCN inhibits canonical WNT signaling via TFE3John C Kennedy, Damir Khabibullin, Thomas Hougard, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 11, 2024
15-epi-lipoxin A<sub>5</sub> promotes neutrophil exit from exudates for clearance by splenic macrophagesHong Yong Peh, Robert Nshimiyimana, Thayse R Brüggemann, et al.
Oncogene|August 18, 2019
Rapamycin-upregulated miR-29b promotes mTORC1-hyperactive cell growth in TSC2-deficient cells by downregulating tumor suppressor retinoic acid receptor β (RARβ)Heng-Jia Liu, Hilaire C Lam, Christian V Baglini, et al.
Scientific Reports|September 23, 2018
Vps34-mediated macropinocytosis in Tuberous Sclerosis Complex 2-deficient cells supports tumorigenesisHarilaos Filippakis, Amine Belaid, Brian Siroky, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Cell Biochemistry and Biophysics|June 27, 2021
Lipid-Derived Mediators are Pivotal to Leukocyte and Lung Cell Responses in Sepsis and ARDSJulie Nijmeh, Bruce D Levy
American Journal of Physiology. Lung Cellular and Molecular Physiology|August 10, 2010
Role of ROS in ischemia-induced lung angiogenesisJulie Nijmeh, Aigul Moldobaeva, Elizabeth M Wagner
Expert Review of Respiratory Medicine|November 25, 2017
Emerging biomarkers of lymphangioleiomyomatosisJulie Nijmeh, Souheil El-Chemaly, Elizabeth P Henske
Experimental Biology and Medicine (Maywood, N.J.)|October 14, 2023
Respiratory viral infection and resolution of inflammation: Roles for specialized pro-resolving mediatorsLuciana P Tavares, Julie Nijmeh, Bruce D Levy
The Journal of Pathology|October 19, 2016
New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complexHilaire C Lam, Julie Nijmeh, Elizabeth P Henske
Current Opinion in Clinical Nutrition and Metabolic Care|December 26, 2021
Specialized pro-resolving mediators in respiratory diseasesR Elaine Cagnina, Melody G Duvall, Julie Nijmeh, et al.
Human Molecular Genetics|July 5, 2019
Loss of FLCN inhibits canonical WNT signaling via TFE3John C Kennedy, Damir Khabibullin, Thomas Hougard, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 11, 2024
15-epi-lipoxin A<sub>5</sub> promotes neutrophil exit from exudates for clearance by splenic macrophagesHong Yong Peh, Robert Nshimiyimana, Thayse R Brüggemann, et al.
Oncogene|August 18, 2019
Rapamycin-upregulated miR-29b promotes mTORC1-hyperactive cell growth in TSC2-deficient cells by downregulating tumor suppressor retinoic acid receptor β (RARβ)Heng-Jia Liu, Hilaire C Lam, Christian V Baglini, et al.
Scientific Reports|September 23, 2018
Vps34-mediated macropinocytosis in Tuberous Sclerosis Complex 2-deficient cells supports tumorigenesisHarilaos Filippakis, Amine Belaid, Brian Siroky, et al.
Pageof 3